Washington § 48.20.389 Prescribed, self-administered anticancer medication.

Washington Statutes

§ 48.20.389 — Prescribed, self-administered anticancer medication.

Washington § 48.20.389

Title 48INSURANCE

Ch. 48.20DISABILITY INSURANCE

This text of Washington § 48.20.389 (Prescribed, self-administered anticancer medication.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Wash. Rev. Code § 48.20.389 (2026).

Text

(1)Each health plan issued or renewed on or after January 1, 2012, that provides coverage for cancer chemotherapy treatment must provide coverage for prescribed, self-administered anticancer medication that is used to kill or slow the growth of cancerous cells on a basis at least comparable to cancer chemotherapy medications administered by a health care provider or facility as defined in *RCW 48.43.005 (25) and (26).

(2)Nothing in this section may be interpreted to prohibit a health plan from administering a formulary or preferred drug list, requiring prior authorization, or imposing other appropriate utilization controls in approving coverage for any chemotherapy. *Reviser's note: RCW 48.43.005 was alphabetized pursuant to RCW 1.08.015 (2)(k), changing subsections (25) and (26) to su

Free access — add to your briefcase to read the full text and ask questions with AI

(1) Each health plan issued or renewed on or after January 1, 2012, that provides coverage for cancer chemotherapy treatment must provide coverage for prescribed, self-administered anticancer medication that is used to kill or slow the growth of cancerous cells on a basis at least comparable to cancer chemotherapy medications administered by a health care provider or facility as defined in *RCW 48.43.005 (25) and (26).

(2) Nothing in this section may be interpreted to prohibit a health plan from administering a formulary or preferred drug list, requiring prior authorization, or imposing other appropriate utilization controls in approving coverage for any chemotherapy.

*Reviser's note: RCW 48.43.005 was alphabetized pursuant to RCW 1.08.015 (2)(k), changing subsections (25) and (26) to subsections (27) and (28). Subsequently, RCW 48.43.005 was amended by 2024 c 218 s 1, changing subsections (27) and (28) to subsections (29) and (30).

Explanatory statement — 2020 c 18: See note following RCW 43.79A.040 .

Findings — 2011 c 159: See note following RCW 41.05.175 .